CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-03 | Bohnen Shane SVP - General Counsel | Shares withheld for taxes | −740 | $53.13 | $39K | 5,904 |
| 2026-04-03 | Bohnen Shane SVP - General Counsel | Option exercise · Restricted Stock Units | −2,259 | 0 | ||
| 2026-03-02 | Crouse Steven C. President - Diag & Spatial Bi | Grant or award · Performance Restricted Stock Units | +2,387 | 2,387 | ||
| 2026-03-02 | Crouse Steven C. President - Diag & Spatial Bi | Grant or award · Restricted Stock Units | +735 | 735 | ||
| 2026-03-02 | Crouse Steven C. President - Diag & Spatial Bi | Grant or award · Stock Option (right to buy) | +1,911 | 1,911 | ||
| 2026-02-17 | Herr Amy E. Director | Sale | −1,976 | $59.11 | $117K | 200 |
| 2026-02-03 | Herr Amy E. Director | Option exercise | +38 | 2,192 | ||
| 2026-02-03 | Herr Amy E. Director | Shares withheld for taxes | −16 | $64.63 | $1K | 2,176 |
| 2026-02-03 | Herr Amy E. Director | Option exercise · Restricted Stock Units | −38 | 77 | ||
| 2026-02-01 | McManus Matthew President - Diag & Spatial Bio | Option exercise | +4,621 | 9,356 | ||
| 2026-02-01 | McManus Matthew President - Diag & Spatial Bio | Shares withheld for taxes | −1,665 | $64.09 | $107K | 7,691 |
| 2026-02-01 | McManus Matthew President - Diag & Spatial Bio | Option exercise · Restricted Stock Units | −4,621 | 4,620 | ||
| 2025-11-03 | Kelderman Kim Chief Executive Officer | Shares withheld for taxes | −2,303 | $62.57 | $144K | 48,665 |
| 2025-11-03 | Hippel James CFO | Option exercise | +13,159 | 143,042 | ||
| 2025-11-03 | Hippel James CFO | Option exercise | +11,545 | 154,587 | ||
| 2025-11-03 | Hippel James CFO | Shares withheld for taxes | −11,865 | $62.57 | $742K | 142,722 |
| 2025-11-03 | Hippel James CFO | Option exercise · Restricted Stock Units | −13,159 | 0 | ||
| 2025-11-03 | Hippel James CFO | Option exercise · Restricted Stock Units | −11,545 | 23,089 | ||
| 2025-11-03 | Geist William PRESIDENT, PROTEIN SCIENCES | Option exercise | +9,911 | 25,023 | ||
| 2025-11-03 | Geist William PRESIDENT, PROTEIN SCIENCES | Shares withheld for taxes | −4,520 | $62.57 | $283K | 20,503 |
Page 8 of 32 · 626 trades